Morimura et al. (26) reported TOX as a tumor cell-specific marker of CTCLs including early MF based on immunohistochemical findings and TOX was expressed in tumor cells of CTCLs but hardly in inflammatory infiltrates of BID. Here, TOX is linked to neoplasm.